API Manager will enable pharma companies to manage complex projects
Hyderabad-based Goose, a specialist pharmaceutical business re-engineering solutions provider recently launched API (Active Pharmaceutical Ingredient) Manager, the only of its kind in the world, fully configurable solution that will enable pharma companies manage complex projects and improve project delivery quality, yield and significantly bring down the cost of project management.
‘Goose API Manager’ is an essential component of any Quality by Design (QbD) initiative, providing the necessary automation, integration and database reporting functionality that ensures all multi-variety data are tracked and measured.
The areas that are likely to witness quantum performance leaps using ‘Goose API Manager’ will be in the five phases of API project management that include project initiation, feasibility, optimisation, validation and drug master filing process, and also their integration.
Deb Pattnaik, Chief Executive Officer, Goose Founder said, “In an environment of extreme cost containment a well-integrated project management solution contributes significantly to pharma business that require product quality enhancements and compliance with strict regulations, as well as improved efficiencies which can lead to reduced costs.”
An important feature of ‘Goose API Manager’ is sequencing and synchronisation of multiple project management activities which is the key to the success of enterprise wide, large scale project management right from initiation stage to drug master filing process. It gives clear visibility of action points related to a project in terms of completion time, reasons for delay and when it could be completed.
The Goose API Manager meets cGMP guidelines and enables pharma companies to connect crucial project management practices maximising business value, communicate project objectives more effectively internally or with third party partners that include systematic treatment of data as well as provide effective technology transfer into the first site of commercial API manufacture.
EP News Bureau — Mumbai